Volufiline formulation: designing for visual skin density and a lipophilic active

Volufiline 100 ml is listed with INCI Hydrogenated Polyisobutene and Anemarrhenae Asphodeloides Root Extract and an oily form. The product information gives a 5% Sederma reference level, oil solubility and use in oil-phase, anhydrous oil and silicone systems.

Lipophilic form controls vehicle choice

Volufiline should not be processed like a water-soluble peptide. A water-based product needs a compatible emulsion or other delivery architecture.

Useful product formats

·        anhydrous oil serum

·        emulsion cream or fluid

·        compatible silicone or hybrid anhydrous system

Emulsion workflow

1.     Define total oil phase.

2.     Include Volufiline in the lipid balance.

3.     Select the emulsification system.

4.     Build the emulsion.

5.     Add the active at an appropriate stage.

6.     Evaluate stability and sensory after cooling.

Cosmetic positioning

Position the ingredient around cosmetic appearance, smoothness and visual density rather than medical lipofilling or guaranteed anatomical volume change.

Internal navigation

Volufiline 5 ml suits trials and 100 ml repeated development.

Conclusion

Volufiline formulation starts with its lipophilic commercial form. Oil-phase design, emulsion architecture and mass-based dosing determine reproducibility.